BIRMINGHAM, Ala. and DANBURY, Conn., Sept. 25, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of its first location in the state of Connecticut: Encompass Health Rehabilitation Hospital of Danbury.
The 40-bed, 50,500-square-foot freestanding hospital provides essential rehabilitation services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain functional ability, independence and quality of life. Patients receive a minimum of three hours of intensive physical, occupational and/or speech therapy five days each week, as well as frequent physician visits and 24-hour nursing care. An interdisciplinary team of highly specialized nurses, therapists and physicians create customized treatment plans to meet each patient's unique recovery goals.
"We're thrilled to bring Encompass Health's high-quality inpatient rehabilitation services to the state of Connecticut," said Mat Gooch, president of Encompass Health's Northeast region. "This hospital will fulfill an important need in the community, enabling patients in the greater Danbury area to recover from serious illnesses and injuries close to their loved ones."
Designed with patients' needs in mind, the hospital will offer amenities such as 40 private patient rooms; a spacious, light-filled therapy gym featuring advanced rehabilitation technologies for every mobility level; an activities of daily living suite with real-world simulated spaces; an in-house dialysis suite; a landscaped therapy courtyard with recreational areas; a dining room; an in-house pharmacy and dayroom areas.
Encompass Health Danbury is Encompass Health's 170th hospital nationwide and its first location in the state of Connecticut.
To learn more, visit encompasshealth.com/locations/danbury-rehab.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 170 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™ and Forbes' Most Trusted Companies in America. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.
From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license.
Encompass Health media contact:
Polly Manuel | 205-970-5912
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$127.18 |
| Daily Change: | 1.05 0.83 |
| Daily Volume: | 574,211 |
| Market Cap: | US$12.810B |
August 07, 2025 August 04, 2025 June 18, 2025 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
